|
|
|
Volumn 41, Issue 1047, 1999, Pages 19-20
|
|
Infliximab (Remicade) for Crohn's disease
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
CLINICAL TRIAL;
CORTICOSTEROID THERAPY;
CROHN DISEASE;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
DRUG SAFETY;
DRUG TOLERABILITY;
DYSPNEA;
FEVER;
HUMAN;
HYPOTENSION;
IMMUNOTHERAPY;
INTESTINE FISTULA;
INTRAVENOUS DRUG ADMINISTRATION;
NAUSEA;
REMISSION;
SERUM SICKNESS;
SHORT SURVEY;
THORAX PAIN;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
CROHN DISEASE;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
DRUG APPROVAL;
HUMANS;
IMMUNIZATION, PASSIVE;
INJECTIONS, INTRAVENOUS;
NAUSEA;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 0033605111
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (19)
|
|
References (0)
|